Literature DB >> 7926511

The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis.

P Layer1, H Yamamoto, L Kalthoff, J E Clain, L J Bakken, E P DiMagno.   

Abstract

BACKGROUND/AIMS: Compared with alcoholic pancreatitis, little is known about the natural history of idiopathic pancreatitis. Two hundred forty-nine patients with alcoholic pancreatitis and 66 patients with idiopathic chronic pancreatitis seen at our institution between 1976 and 1982 were investigated.
METHODS: Records were analyzed retrospectively from the onset of symptomatic disease, and patients were followed up prospectively until 1985. Patients with early-onset (n = 25) and late-onset (n = 41) idiopathic chronic pancreatitis had a median age at onset of symptoms of 19 and 56 years, respectively.
RESULTS: The gender distribution was nearly equal in idiopathic chronic pancreatitis, but 72% of patients with alcoholic pancreatitis were men (P = 0.001 vs. idiopathic). In early-onset idiopathic pancreatitis, calcification and exocrine and endocrine insufficiency developed more slowly than in late-onset idiopathic and alcoholic pancreatitis (P = 0.03). However, in early idiopathic chronic pancreatitis, pain frequently occurred initially (P = 0.003 vs. late and alcoholic) and was more severe (P = 0.04 vs. late and alcoholic). In late-onset idiopathic pancreatitis, pain was absent in nearly 50% of patients.
CONCLUSIONS: There are two distinct forms of idiopathic chronic pancreatitis. Patients with early-onset pancreatitis have initially and thereafter a long course of severe pain but slowly develop morphological and functional pancreatic damage, whereas patients with late-onset pancreatitis have a mild and often a painless course. Both forms differ from alcoholic pancreatitis in their equal gender distribution and a much slower rate of calcification.

Entities:  

Mesh:

Year:  1994        PMID: 7926511     DOI: 10.1016/0016-5085(94)90553-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  137 in total

Review 1.  Pancreatic enzyme replacement therapy.

Authors:  P Layer; J Keller; P G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 2.  Pathogenesis of pain in chronic pancreatitis: ongoing enigma.

Authors:  Philippus C Bornman; Israel N Marks; Andrew W Girdwood; Pascal O Berberat; Antanas Gulbinas; Markus W Büchler
Journal:  World J Surg       Date:  2003-10-27       Impact factor: 3.352

3.  End-stage chronic pancreatitis: a practical disease-descriptor.

Authors:  H P Siriwardana; A K Siriwardena
Journal:  Int J Gastrointest Cancer       Date:  2001

4.  The analgesic effect of pregabalin in patients with chronic pain is reflected by changes in pharmaco-EEG spectral indices.

Authors:  Carina Graversen; Søren S Olesen; Anne E Olesen; Kristoffer Steimle; Dario Farina; Oliver H G Wilder-Smith; Stefan A W Bouwense; Harry van Goor; Asbjørn M Drewes
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

5.  Gremlin1 and chronic pancreatitis: a new clinical target and biomarker?

Authors:  Derek P Brazil
Journal:  J Mol Med (Berl)       Date:  2015-10       Impact factor: 4.599

6.  What is the role of endotherapy in chronic pancreatitis?

Authors:  Haritha Avula; Stuart Sherman
Journal:  Therap Adv Gastroenterol       Date:  2010-11       Impact factor: 4.409

Review 7.  Idiopathic recurrent acute pancreatitis.

Authors:  Luis F Lara; Michael J Levy
Journal:  MedGenMed       Date:  2004-11-15

Review 8.  New advances in acute pancreatitis.

Authors:  Matthew J DiMagno; Eugene P DiMagno
Journal:  Curr Opin Gastroenterol       Date:  2007-09       Impact factor: 3.287

9.  Exocrine pancreatic insufficiency after allogeneic bone marrow transplantation.

Authors:  A Maringhini; M A Gertz; E P DiMagno
Journal:  Int J Pancreatol       Date:  1995-06

10.  The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.

Authors:  Chris E Forsmark; Gong Tang; Hongzhi Xu; Marie Tuft; Steven J Hughes; Dhiraj Yadav
Journal:  Aliment Pharmacol Ther       Date:  2020-04-06       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.